CVRX — CVRx Inc

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

About CVRx Inc

CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased baroreceptor signaling, and provides baroreflex act… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$5.63
Market Cap$163M
Float18.4M
Shares Outstanding26.5M
Price/Sales (TTM)2.76
vs. Analyst Target+98.3% to analyst PT
Profit Margin-89.15%
Operating Margin (TTM)-82.34%
Revenue (TTM)$59.1M
Dividend RateNone
Analyst Target Price$11.17 (7 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 $6.1M -$14.1M $4.6M -$11.5M
2021 $13.0M -$43.1M $9.4M -$40.6M
2022 $22.5M -$41.4M $17.5M -$40.7M
2023 $39.3M -$41.2M $33.0M -$43.1M
2024 $51.3M -$60.0M $43.0M -$54.9M
2025 $56.7M -$53.3M $48.3M -$46.7M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 $13.6M -$14.7M
Sep 2025 $14.7M -$12.9M
Dec 2025 $16.0M -$11.9M
Mar 2026 $14.8M -$13.1M

Ownership & Float

Insider Ownership9.3%
Institutional Ownership63.6%
Short Float9.5%
% of All Funds Holding1.07%
Number of Funds Holding88

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$7.27Near-term / short-term trend
Weekly40-Week SMA$7.89Medium-term trend
Weekly80-Week SMA$9.10Cyclical trend (business cycle)
Weekly200-Week SMA$12.10Secular trend (multi-year)
Monthly10-Month SMA$8.06Near-term monthly trend
Monthly20-Month SMA$9.54Medium-term monthly trend
Monthly40-Month SMA$12.28Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$7.50 resistance 1.30x 0 months ago
$9.50 resistance 1.01x 0 months ago
$12.30 resistance 1.84x 12 months ago

Historical Earnings Reactions (20 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap -0.96% 0.62% 55.00% 15.65% -38.68%
1 Day -0.43% 1.76% 60.00% 31.01% -46.27%
1 Week 2.91% -0.57% 45.00% 43.58% -49.77%
2 Weeks -1.21% -3.01% 40.00% 32.48% -48.03%
1 Month -3.14% -0.37% 50.00% 49.38% -58.67%

Next earnings: July 30, 2026 (62 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

Insufficient historical data for monthly seasonality analysis (requires 7+ years of data).

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday -0.07% 43.4% 228
Tuesday -0.14% 50.2% 255
Wednesday -0.02% 49.6% 252
Thursday 0.10% 45.9% 246
Friday 0.40% 50.2% 249

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 63.6%

Insider Transactions — Smart Summary

Total insider ownership: 9.3%

12-Month Insider Activity Summary

Total Filings12
Net Value-$126,575.111
Net Shares Change287,477
% of Float1.6%
C-Suite Filings5
Clusters Detected1

Key Insiders

NameTitleNet ValueFilingsActivity
JOHNSON and JOHNSON -$314,732.25 3 3 sell
Jain Mudit K. +$300,376.86 2 2 buy
Hykes Kevin PRES and CEO -$61,348.66 1 N/A
John Robert Allen Chief Revenue Officer -$31,325.51 1 N/A
OASHEIM JARED CHIEF FINANCIAL OFFICER -$13,781.437 1 N/A
VERRASTRO PAUL CHIEF MKTG and STRAT OFFICER -$10,146.296 1 N/A
Adamson Philip B. Chief Medical Officer -$9,973.207 1 N/A

Transaction Clusters

PeriodFilingsInsidersNet ValueSeniority
2026-02-18 – 2026-03-03 6 5 +$183,774.957 4 C-suite

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-02-23 Jain Mudit K. +$297,591.84 Transaction at $6.36, now -11.5%
2026-02-18 Jain Mudit K. +$2,785.02 Transaction at $4.64, now +21.3%
2026-03-16 Adamson Philip B. Chief Medical Officer -$9,973.207 Transaction at $7.90, now -28.8%
2026-03-03 VERRASTRO PAUL CHIEF MKTG and STRAT OFFICER -$10,146.296 Transaction at $7.90, now -28.8%
2026-03-03 OASHEIM JARED CHIEF FINANCIAL OFFICER -$13,781.437 Transaction at $7.90, now -28.8%
2026-03-03 John Robert Allen Chief Revenue Officer -$31,325.51 Transaction at $7.90, now -28.8%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for CVRx Inc (CVRX) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for CVRX on Trend Edge →